Predictive And Prognostic Value Of Hepatic Steatosis In Conversion Therapy For Colorectal Liver-limited Metastases: A Propensity Score Matching Analysis.

Mi Jian Wenju ChangLi RenTianyu LiuYijiao ChenYe WeiQi LinJianmin XuXinyu Qin

Published in: Cancer management and research (2019)

For CLLM patients who underwent conversion therapy, hepatic steatosis could be an effective predictor for conversion hepatectomy rate and an independent prognostic factor for PFS and OS.

Keyphrases

prognostic factors
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
stem cells
patient reported outcomes
smoking cessation